Healthcare provider profile · identity verified

Madison Humerick, MD

Family Practice · HARPERS FERRY, WV · NPI 1841610318

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	173	58
Gabapentin	Gabapentin	124	33
Amlodipine Besylate	Amlodipine Besylate	116	37
Lisinopril	Lisinopril	98	30
Levothyroxine Sodium	Levothyroxine Sodium	91	27
Eliquis	Apixaban	72	17
Trazodone Hcl	Trazodone Hcl	72	17
Metformin Hcl Er	Metformin Hcl	70	20
Rosuvastatin Calcium	Rosuvastatin Calcium	69	21
Oxycodone Hcl	Oxycodone Hcl	65	11
Ozempic	Semaglutide	62	18
Pantoprazole Sodium	Pantoprazole Sodium	61	19
Losartan Potassium	Losartan Potassium	57	21
Hydrochlorothiazide	Hydrochlorothiazide	56	17
Furosemide	Furosemide	54	25
Famotidine	Famotidine	53	20
Metoprolol Succinate	Metoprolol Succinate	52	18
Albuterol Sulfate Hfa	Albuterol Sulfate	49	18
Sertraline Hcl	Sertraline Hcl	48	14
Alendronate Sodium	Alendronate Sodium	47	15
Prednisone	Prednisone	46	22
Cephalexin	Cephalexin	45	21
Mounjaro	Tirzepatide	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	suppressed
Metformin Hcl	Metformin Hcl	41	16
Duloxetine Hcl	Duloxetine Hcl	37	12
Omeprazole	Omeprazole	37	13
Tramadol Hcl	Tramadol Hcl	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Bupropion Xl	Bupropion Hcl	33	11
Doxycycline Hyclate	Doxycycline Hyclate	33	25
Fluticasone Propionate	Fluticasone Propionate	33	15
Tamsulosin Hcl	Tamsulosin Hcl	33	11
Ondansetron Odt	Ondansetron	31	suppressed
Mirtazapine	Mirtazapine	30	12
Allopurinol	Allopurinol	29	suppressed
Carvedilol	Carvedilol	28	13
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Clotrimazole	Clotrimazole	26	suppressed
Simvastatin	Simvastatin	26	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Meloxicam	Meloxicam	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Alprazolam	Alprazolam	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Finasteride	Finasteride	13	suppressed
Lactulose	Lactulose	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Nyamyc	Nystatin	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Linzess	Linaclotide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error